Clinicopathologic characteristics, treatment outcomes, and acquired resistance patterns of atypical EGFR mutations and HER2 alterations in stage IV non–small-cell …
T Patil, R Mushtaq, S Marsh, C Azelby, M Pujara… - Clinical lung cancer, 2020 - Elsevier
Background The clinicopathologic characteristics, acquired resistance patterns, and
outcomes among patients with atypical EGFR mutations and HER2 alterations remain …
outcomes among patients with atypical EGFR mutations and HER2 alterations remain …
[PDF][PDF] Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non …
T Patil, R Mushtaq, S Marsh, C Azelby, M Pujara… - Clin Lung …, 2020 - researchgate.net
The outcomes for atypical EGFR and HER2 alterations remain underexplored. We
performed a single-center retrospective study to determine unique clinical characteristics …
performed a single-center retrospective study to determine unique clinical characteristics …
[HTML][HTML] Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non …
T Patil, R Mushtaq, S Marsh, C Azelby… - Clinical lung …, 2020 - ncbi.nlm.nih.gov
The outcomes for atypical EGFR and HER2 alterations remain underexplored. We
performed a single-center retrospective study to determine unique clinical characteristics …
performed a single-center retrospective study to determine unique clinical characteristics …
Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small …
T Patil, R Mushtaq, S Marsh, C Azelby… - Clinical lung …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The clinicopathologic characteristics, acquired resistance patterns, and
outcomes among patients with atypical EGFR mutations and HER2 alterations remain …
outcomes among patients with atypical EGFR mutations and HER2 alterations remain …
Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small …
T Patil, R Mushtaq, S Marsh, C Azelby… - Clinical Lung …, 2019 - europepmc.org
Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of
Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer …
Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer …
Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non–Small …
T Patil, R Mushtaq, S Marsh, C Azelby… - Clinical Lung …, 2020 - clinical-lung-cancer.com
Background The clinicopathologic characteristics, acquired resistance patterns, and
outcomes among patients with atypical EGFR mutations and HER2 alterations remain …
outcomes among patients with atypical EGFR mutations and HER2 alterations remain …
Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small …
T Patil, R Mushtaq, S Marsh, C Azelby… - Clinical Lung …, 2019 - europepmc.org
Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of
Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer …
Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer …